269 related articles for article (PubMed ID: 31598691)
1. The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells.
Ogara MF; Rodríguez-Seguí SA; Marini M; Nacht AS; Stortz M; Levi V; Presman DM; Vicent GP; Pecci A
Nucleic Acids Res; 2019 Nov; 47(20):10645-10661. PubMed ID: 31598691
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor directly inhibits β-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications.
Buser AC; Obr AE; Kabotyanski EB; Grimm SL; Rosen JM; Edwards DP
Mol Endocrinol; 2011 Jun; 25(6):955-68. PubMed ID: 21527503
[TBL] [Abstract][Full Text] [Related]
3. Differential activation of the IkappaBalpha and mouse mammary tumor virus promoters by progesterone and glucocorticoid receptors.
Deroo BJ; Archer TK
J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):309-17. PubMed ID: 12361720
[TBL] [Abstract][Full Text] [Related]
4. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
[TBL] [Abstract][Full Text] [Related]
5. Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activity.
Karmakar S; Jin Y; Nagaich AK
J Biol Chem; 2013 Aug; 288(33):24020-34. PubMed ID: 23814048
[TBL] [Abstract][Full Text] [Related]
6. CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin.
Vallejo G; La Greca AD; Tarifa-Reischle IC; Mestre-Citrinovitz AC; Ballaré C; Beato M; Saragüeta P
PLoS One; 2014; 9(5):e97311. PubMed ID: 24859236
[TBL] [Abstract][Full Text] [Related]
7. Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines.
Ewing TM; Murphy LJ; Ng ML; Pang GY; Lee CS; Watts CK; Sutherland RL
Int J Cancer; 1989 Oct; 44(4):744-52. PubMed ID: 2793247
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells.
Buser AC; Gass-Handel EK; Wyszomierski SL; Doppler W; Leonhardt SA; Schaack J; Rosen JM; Watkin H; Anderson SM; Edwards DP
Mol Endocrinol; 2007 Jan; 21(1):106-25. PubMed ID: 16973758
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in Breast Cancer Cells.
Davaadelger B; Murphy AR; Clare SE; Lee O; Khan SA; Kim JJ
Endocrinology; 2018 Oct; 159(10):3581-3595. PubMed ID: 30203004
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
Faivre EJ; Daniel AR; Hillard CJ; Lange CA
Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association.
Tonsing-Carter E; Hernandez KM; Kim CR; Harkless RV; Oh A; Bowie KR; West-Szymanski DC; Betancourt-Ponce MA; Green BD; Lastra RR; Fleming GF; Chandarlapaty S; Conzen SD
Breast Cancer Res; 2019 Jul; 21(1):82. PubMed ID: 31340854
[TBL] [Abstract][Full Text] [Related]
12. [Binding characteristics of RU 486 with glucocorticoid and progestin receptors].
Fukuoka H; Jimbo T
Nihon Naibunpi Gakkai Zasshi; 1988 Aug; 64(8):698-706. PubMed ID: 3224726
[TBL] [Abstract][Full Text] [Related]
13. The mouse mammary tumor virus promoter adopts distinct chromatin structures in human breast cancer cells with and without glucocorticoid receptor.
Kinyamu HK; Fryer CJ; Horwitz KB; Archer TK
J Biol Chem; 2000 Jun; 275(26):20061-8. PubMed ID: 10751396
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.
Courtin A; Communal L; Vilasco M; Cimino D; Mourra N; de Bortoli M; Taverna D; Faussat AM; Chaouat M; Forgez P; Gompel A
Breast Cancer Res Treat; 2012 Jan; 131(1):49-63. PubMed ID: 21336598
[TBL] [Abstract][Full Text] [Related]
15. Multimodal regulation of E2F1 gene expression by progestins.
Wade HE; Kobayashi S; Eaton ML; Jansen MS; Lobenhofer EK; Lupien M; Geistlinger TR; Zhu W; Nevins JR; Brown M; Otteson DC; McDonnell DP
Mol Cell Biol; 2010 Apr; 30(8):1866-77. PubMed ID: 20123965
[TBL] [Abstract][Full Text] [Related]
16. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
[TBL] [Abstract][Full Text] [Related]
17. The differential capacity of glucocorticoids and progestins to alter chromatin structure and induce gene expression in human breast cancer cells.
Archer TK; Zaniewski E; Moyer ML; Nordeen SK
Mol Endocrinol; 1994 Sep; 8(9):1154-62. PubMed ID: 7838148
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid and progestin receptors are differently involved in the cooperation with a structural element of the mouse mammary tumor virus promoter.
Le Ricousse S; Gouilleux F; Fortin D; Joulin V; Richard-Foy H
Proc Natl Acad Sci U S A; 1996 May; 93(10):5072-7. PubMed ID: 8643531
[TBL] [Abstract][Full Text] [Related]
19. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
[TBL] [Abstract][Full Text] [Related]
20. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
Diep CH; Ahrendt H; Lange CA
Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]